NASDAQ · Medical Care Facilities · USD
Astrana Health, Inc. (ASTH) Stock Analysis
Astrana Health, Inc. (ASTH) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ASTH Key Statistics
As of Sep 4, 2026Trading
- Open
- $37.65
- Previous Close
- $37.83
- Day's Range
- 37.22–39.24
- 52-Week Range
- 18.08–51.60
- Volume
- 242.00K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.91
Valuation
- Market Cap
- $1.91B
- P/E Ratio
- 46.35
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 10.87
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.50
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.83
Financials (FY)
- Revenue (FY)
- $3.18B+56.39%
- Net Income (FY)
- $22.49M−47.89%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 1.05%
- Shares Outstanding
- 49.60M
- 1-Year Return
- +24.82%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 591.83K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
ASTH Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +55.06% |
| 2025 | −21.31% |
| 2024 | −17.68% |
| 2023 | +29.44% |
| 2022 | −59.73% |
| 2021 | +302.19% |
| 2020 | −0.76% |
| 2019 | −7.25% |
| 2018 | −17.29% |
| 2017 | +220.00% |
| 2016 (partial year) | +56.58% |
As of September 4, 2026.
ASTH Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.18B | $22.49M | 0.7% |
| 2024 | $2.03B | $43.15M | 2.1% |
| 2023 | $1.39B | $60.72M | 4.4% |
| 2022 | $1.14B | $45.17M | 3.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.18B | $341.53M | $78.53M | $22.49M | 0.7% |
| 2024 | $2.03B | $271.39M | $89.35M | $43.15M | 2.1% |
| 2023 | $1.39B | $214.96M | $84.61M | $60.72M | 4.4% |
| 2022 | $1.14B | $199.48M | $104.27M | $45.17M | 3.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
ASTH Valuation vs Medical Care Facilities Median
Median of 57 stocks| Metric | ASTH | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 46.35 | 19.84 | 134% above |
| P/S ratio | 0.50 | 0.95 | 48% below |
| Profit margin | 1.05% | 3.06% | 2.0 pts below |
Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Astrana Health: 81% Full-Risk And Profitable
SeekingAlphaTruist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
BenzingaBarclays Maintains Overweight on Astrana Health, Raises Price Target to $53
BenzingaAstrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript
SeekingAlphaAstrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat
ChartMillAstrana Health, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha
All 9 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$87.68B
THCTenet Healthcare Corporation
$21.34B
FMSFresenius Medical Care AG
$12.06B
EHCEncompass Health Corporation
$12.01B
DVADaVita Inc.
$11.74B
UHSUniversal Health Services, Inc.
$10.00B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B








